| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.28e-09 | 188 | 36 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | heparin binding | 1.12e-06 | 192 | 36 | 6 | GO:0008201 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 1.52e-06 | 323 | 36 | 7 | GO:1901681 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 7.68e-06 | 268 | 36 | 6 | GO:0005539 | |
| GeneOntologyMolecularFunction | growth factor binding | 8.46e-06 | 156 | 36 | 5 | GO:0019838 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 8.86e-06 | 73 | 36 | 4 | GO:0050840 | |
| GeneOntologyMolecularFunction | neuregulin receptor activity | 9.47e-06 | 3 | 36 | 2 | GO:0038131 | |
| GeneOntologyMolecularFunction | integrin binding | 1.48e-05 | 175 | 36 | 5 | GO:0005178 | |
| GeneOntologyMolecularFunction | neuregulin binding | 4.72e-05 | 6 | 36 | 2 | GO:0038132 | |
| GeneOntologyMolecularFunction | structural molecule activity | 1.51e-04 | 891 | 36 | 8 | GO:0005198 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 2.18e-04 | 65 | 36 | 3 | GO:0004714 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 4.80e-04 | 85 | 36 | 3 | GO:0019199 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 6.43e-04 | 599 | 36 | 6 | GO:0050839 | |
| GeneOntologyMolecularFunction | receptor serine/threonine kinase binding | 1.81e-03 | 35 | 36 | 2 | GO:0033612 | |
| GeneOntologyMolecularFunction | calcium ion binding | 2.03e-03 | 749 | 36 | 6 | GO:0005509 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 2.25e-03 | 145 | 36 | 3 | GO:0004713 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 3.12e-06 | 372 | 36 | 7 | GO:0060485 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | ERBB3 ERBB4 LTBP2 HTRA4 CRIM1 IGFBP6 CCN1 TNXB SVEP1 NPNT WIF1 | 3.44e-06 | 1186 | 36 | 11 | GO:0007167 |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 4.33e-06 | 63 | 36 | 4 | GO:0003179 | |
| GeneOntologyBiologicalProcess | heart development | 4.45e-06 | 757 | 36 | 9 | GO:0007507 | |
| GeneOntologyBiologicalProcess | heart valve development | 1.02e-05 | 78 | 36 | 4 | GO:0003170 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 1.13e-05 | 850 | 36 | 9 | GO:0071363 | |
| GeneOntologyBiologicalProcess | response to growth factor | 1.54e-05 | 883 | 36 | 9 | GO:0070848 | |
| GeneOntologyBiologicalProcess | atrioventricular valve morphogenesis | 1.55e-05 | 28 | 36 | 3 | GO:0003181 | |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 1.72e-05 | 89 | 36 | 4 | GO:0060411 | |
| GeneOntologyBiologicalProcess | atrioventricular valve development | 2.34e-05 | 32 | 36 | 3 | GO:0003171 | |
| GeneOntologyBiologicalProcess | striated muscle cell proliferation | 3.95e-05 | 110 | 36 | 4 | GO:0014855 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 8.54e-05 | 134 | 36 | 4 | GO:0003279 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.10e-04 | 445 | 36 | 6 | GO:0141091 | |
| GeneOntologyBiologicalProcess | circulatory system development | 1.28e-04 | 1442 | 36 | 10 | GO:0072359 | |
| GeneOntologyBiologicalProcess | endocardial cushion development | 1.41e-04 | 58 | 36 | 3 | GO:0003197 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | 1.57e-04 | 1190 | 36 | 9 | GO:0008284 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.70e-04 | 482 | 36 | 6 | GO:0007178 | |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 1.73e-04 | 161 | 36 | 4 | GO:0003206 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | 2.25e-04 | 321 | 36 | 5 | GO:0003007 | |
| GeneOntologyBiologicalProcess | muscle cell proliferation | 2.52e-04 | 329 | 36 | 5 | GO:0033002 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 2.54e-04 | 1269 | 36 | 9 | GO:0009887 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell proliferation | 3.93e-04 | 82 | 36 | 3 | GO:0060038 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 4.94e-04 | 212 | 36 | 4 | GO:0003205 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate catabolic process | 4.97e-04 | 19 | 36 | 2 | GO:0034031 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate catabolic process | 4.97e-04 | 19 | 36 | 2 | GO:0034034 | |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate catabolic process | 4.97e-04 | 19 | 36 | 2 | GO:0033869 | |
| GeneOntologyBiologicalProcess | ventricular septum development | 5.34e-04 | 91 | 36 | 3 | GO:0003281 | |
| GeneOntologyBiologicalProcess | muscle structure development | 6.10e-04 | 858 | 36 | 7 | GO:0061061 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 7.02e-04 | 412 | 36 | 5 | GO:0090287 | |
| GeneOntologyBiologicalProcess | neural crest cell differentiation | 7.88e-04 | 104 | 36 | 3 | GO:0014033 | |
| GeneOntologyBiologicalProcess | atrial septum development | 8.66e-04 | 25 | 36 | 2 | GO:0003283 | |
| GeneOntologyBiologicalProcess | olfactory bulb interneuron differentiation | 9.38e-04 | 26 | 36 | 2 | GO:0021889 | |
| GeneOntologyBiologicalProcess | ERBB2 signaling pathway | 1.01e-03 | 27 | 36 | 2 | GO:0038128 | |
| GeneOntologyBiologicalProcess | body fluid secretion | 1.22e-03 | 121 | 36 | 3 | GO:0007589 | |
| GeneOntologyCellularComponent | extracellular matrix | LAMC2 LTBP2 ADAMTS5 IGFBP6 CCN1 MUC2 USH2A SSPOP TNXB SVEP1 NPNT | 7.86e-09 | 656 | 36 | 11 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LAMC2 LTBP2 ADAMTS5 IGFBP6 CCN1 MUC2 USH2A SSPOP TNXB SVEP1 NPNT | 8.12e-09 | 658 | 36 | 11 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.42e-08 | 530 | 36 | 10 | GO:0062023 | |
| GeneOntologyCellularComponent | basement membrane | 1.20e-03 | 122 | 36 | 3 | GO:0005604 | |
| MousePheno | abnormal mandibular nerve morphology | 2.79e-07 | 7 | 29 | 3 | MP:0009800 | |
| MousePheno | abnormal trigeminal nerve morphology | 3.77e-06 | 52 | 29 | 4 | MP:0001065 | |
| MousePheno | abnormal fetal atrioventricular canal morphology | 2.23e-05 | 81 | 29 | 4 | MP:0006107 | |
| MousePheno | abnormal basal lamina morphology | 6.20e-05 | 6 | 29 | 2 | MP:0004273 | |
| MousePheno | lens dislocation | 6.20e-05 | 6 | 29 | 2 | MP:0031428 | |
| MousePheno | absent upper incisors | 1.48e-04 | 9 | 29 | 2 | MP:0004790 | |
| Domain | Growth_fac_rcpt_ | LAMC2 ERBB3 ERBB4 LTBP2 HTRA4 CELSR2 CRIM1 IGFBP6 CCN1 TNXB SVEP1 SLIT3 NPNT | 7.30e-19 | 156 | 35 | 13 | IPR009030 |
| Domain | EGF_1 | LAMC2 LTBP2 TENM4 CELSR2 EGFL8 USH2A SSPOP TNXB VWDE SVEP1 MEGF10 SLIT3 NPNT WIF1 | 9.83e-18 | 255 | 35 | 14 | PS00022 |
| Domain | EGF_2 | LAMC2 LTBP2 TENM4 CELSR2 EGFL8 SSPOP TNXB VWDE SVEP1 MEGF10 SLIT3 NPNT WIF1 | 7.87e-16 | 265 | 35 | 13 | PS01186 |
| Domain | EGF_3 | LTBP2 TENM4 CELSR2 EGFL8 SSPOP TNXB VWDE SVEP1 MEGF10 SLIT3 NPNT WIF1 | 7.68e-15 | 235 | 35 | 12 | PS50026 |
| Domain | EGF | LAMC2 LTBP2 TENM4 CELSR2 EGFL8 TNXB VWDE SVEP1 MEGF10 SLIT3 NPNT WIF1 | 7.68e-15 | 235 | 35 | 12 | SM00181 |
| Domain | EGF-like_dom | LAMC2 LTBP2 TENM4 CELSR2 EGFL8 TNXB VWDE SVEP1 MEGF10 SLIT3 NPNT WIF1 | 1.54e-14 | 249 | 35 | 12 | IPR000742 |
| Domain | EGF-like_CS | LAMC2 LTBP2 TENM4 CELSR2 EGFL8 TNXB VWDE SVEP1 MEGF10 SLIT3 NPNT WIF1 | 2.70e-14 | 261 | 35 | 12 | IPR013032 |
| Domain | EGF_extracell | 1.28e-09 | 60 | 35 | 6 | IPR013111 | |
| Domain | EGF_2 | 1.28e-09 | 60 | 35 | 6 | PF07974 | |
| Domain | EGF | 3.09e-09 | 126 | 35 | 7 | PF00008 | |
| Domain | CTCK_1 | 3.10e-08 | 18 | 35 | 4 | PS01185 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.11e-08 | 106 | 35 | 6 | IPR000152 | |
| Domain | IGFBP_N_2 | 4.90e-08 | 20 | 35 | 4 | PS51323 | |
| Domain | IGFBP-like | 4.90e-08 | 20 | 35 | 4 | IPR000867 | |
| Domain | IGFBP | 4.90e-08 | 20 | 35 | 4 | PF00219 | |
| Domain | EGF_CA | 9.54e-08 | 122 | 35 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.05e-07 | 124 | 35 | 6 | IPR001881 | |
| Domain | Cys_knot_C | 1.27e-07 | 25 | 35 | 4 | IPR006207 | |
| Domain | CTCK_2 | 1.27e-07 | 25 | 35 | 4 | PS01225 | |
| Domain | hEGF | 2.05e-07 | 28 | 35 | 4 | PF12661 | |
| Domain | Laminin_EGF | 5.19e-07 | 35 | 35 | 4 | PF00053 | |
| Domain | EGF_Lam | 5.19e-07 | 35 | 35 | 4 | SM00180 | |
| Domain | VWFC_1 | 5.83e-07 | 36 | 35 | 4 | PS01208 | |
| Domain | VWC | 7.29e-07 | 38 | 35 | 4 | SM00214 | |
| Domain | Laminin_EGF | 7.29e-07 | 38 | 35 | 4 | IPR002049 | |
| Domain | VWFC_2 | 7.29e-07 | 38 | 35 | 4 | PS50184 | |
| Domain | EGF_Ca-bd_CS | 9.77e-07 | 97 | 35 | 5 | IPR018097 | |
| Domain | EGF_CA | 1.08e-06 | 99 | 35 | 5 | PS01187 | |
| Domain | VWF_dom | 1.10e-06 | 42 | 35 | 4 | IPR001007 | |
| Domain | ASX_HYDROXYL | 1.14e-06 | 100 | 35 | 5 | PS00010 | |
| Domain | VWFD | 3.32e-06 | 16 | 35 | 3 | PS51233 | |
| Domain | VWD | 3.32e-06 | 16 | 35 | 3 | SM00216 | |
| Domain | VWF_type-D | 3.32e-06 | 16 | 35 | 3 | IPR001846 | |
| Domain | VWD | 3.32e-06 | 16 | 35 | 3 | PF00094 | |
| Domain | EMI | 4.03e-06 | 17 | 35 | 3 | PS51041 | |
| Domain | IB | 4.83e-06 | 18 | 35 | 3 | SM00121 | |
| Domain | TSP_1 | 5.69e-06 | 63 | 35 | 4 | PF00090 | |
| Domain | VWC_out | 5.72e-06 | 19 | 35 | 3 | SM00215 | |
| Domain | TSP1 | 6.45e-06 | 65 | 35 | 4 | SM00209 | |
| Domain | TSP1_rpt | 6.45e-06 | 65 | 35 | 4 | IPR000884 | |
| Domain | TSP1 | 6.45e-06 | 65 | 35 | 4 | PS50092 | |
| Domain | CT | 9.06e-06 | 22 | 35 | 3 | SM00041 | |
| Domain | EGF_CA | 1.97e-05 | 86 | 35 | 4 | PF07645 | |
| Domain | Tyr_kinase_EGF/ERB/XmrK_rcpt | 2.04e-05 | 4 | 35 | 2 | IPR016245 | |
| Domain | EGF_LAM_2 | 2.36e-05 | 30 | 35 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 2.36e-05 | 30 | 35 | 3 | PS01248 | |
| Domain | - | 2.91e-05 | 95 | 35 | 4 | 2.60.120.200 | |
| Domain | LAM_G_DOMAIN | 4.86e-05 | 38 | 35 | 3 | PS50025 | |
| Domain | WxxW_domain | 5.09e-05 | 6 | 35 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 5.09e-05 | 6 | 35 | 2 | PF13330 | |
| Domain | GF_recep_IV | 5.09e-05 | 6 | 35 | 2 | PF14843 | |
| Domain | GF_recep_IV | 5.09e-05 | 6 | 35 | 2 | IPR032778 | |
| Domain | ConA-like_dom | 5.16e-05 | 219 | 35 | 5 | IPR013320 | |
| Domain | Laminin_G_2 | 5.68e-05 | 40 | 35 | 3 | PF02210 | |
| Domain | Furin-like | 7.12e-05 | 7 | 35 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 7.12e-05 | 7 | 35 | 2 | IPR000494 | |
| Domain | Furin-like_Cys-rich_dom | 7.12e-05 | 7 | 35 | 2 | IPR006211 | |
| Domain | Recep_L_domain | 7.12e-05 | 7 | 35 | 2 | PF01030 | |
| Domain | - | 7.12e-05 | 7 | 35 | 2 | 3.80.20.20 | |
| Domain | LamG | 7.57e-05 | 44 | 35 | 3 | SM00282 | |
| Domain | Laminin_G | 1.73e-04 | 58 | 35 | 3 | IPR001791 | |
| Domain | TIL | 2.23e-04 | 12 | 35 | 2 | PF01826 | |
| Domain | IGFBP_N_1 | 2.23e-04 | 12 | 35 | 2 | PS00222 | |
| Domain | C8 | 2.23e-04 | 12 | 35 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 2.63e-04 | 13 | 35 | 2 | IPR014853 | |
| Domain | C8 | 2.63e-04 | 13 | 35 | 2 | SM00832 | |
| Domain | TIL_dom | 3.06e-04 | 14 | 35 | 2 | IPR002919 | |
| Domain | EMI_domain | 4.03e-04 | 16 | 35 | 2 | IPR011489 | |
| Domain | CarboxyPept-like_regulatory | 4.56e-04 | 17 | 35 | 2 | IPR008969 | |
| Domain | Furin_repeat | 5.12e-04 | 18 | 35 | 2 | IPR006212 | |
| Domain | FU | 5.12e-04 | 18 | 35 | 2 | SM00261 | |
| Domain | VWC | 1.25e-03 | 28 | 35 | 2 | PF00093 | |
| Domain | L_dom-like | 3.18e-03 | 328 | 35 | 4 | IPR032675 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 1.92e-04 | 11 | 27 | 2 | MM15478 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 2.72e-04 | 13 | 27 | 2 | M27729 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 2.72e-04 | 13 | 27 | 2 | MM15320 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 3.17e-04 | 14 | 27 | 2 | MM14761 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 3.17e-04 | 14 | 27 | 2 | MM14531 | |
| Pathway | PID_ERBB_NETWORK_PATHWAY | 3.65e-04 | 15 | 27 | 2 | M201 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 3.65e-04 | 15 | 27 | 2 | M27608 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 4.17e-04 | 16 | 27 | 2 | M570 | |
| Pathway | WP_ERBB_SIGNALING | 7.02e-04 | 92 | 27 | 3 | M39715 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 7.97e-04 | 22 | 27 | 2 | M26929 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 8.72e-04 | 23 | 27 | 2 | MM1480 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 8.72e-04 | 23 | 27 | 2 | M18719 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 1.03e-03 | 25 | 27 | 2 | M47934 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_IN_CANCER | 1.12e-03 | 26 | 27 | 2 | M29535 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 1.12e-03 | 26 | 27 | 2 | MM15501 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.15e-03 | 109 | 27 | 3 | MM15164 | |
| Pathway | REACTOME_PI3K_AKT_SIGNALING_IN_CANCER | 1.18e-03 | 110 | 27 | 3 | M27162 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 1.39e-03 | 29 | 27 | 2 | M27756 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4 | 1.80e-03 | 33 | 27 | 2 | M39455 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB4 | 1.80e-03 | 33 | 27 | 2 | MM14523 | |
| Pathway | PID_ERBB4_PATHWAY | 2.38e-03 | 38 | 27 | 2 | M13 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.40e-03 | 300 | 27 | 4 | M610 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.51e-03 | 39 | 27 | 2 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.51e-03 | 39 | 27 | 2 | MM15165 | |
| Pathway | PID_ATR_PATHWAY | 2.51e-03 | 39 | 27 | 2 | M46 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 3.18e-03 | 44 | 27 | 2 | MM14520 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 3.47e-03 | 46 | 27 | 2 | M239 | |
| Pathway | PID_PS1_PATHWAY | 3.47e-03 | 46 | 27 | 2 | M70 | |
| Pathway | WP_ERBB_SIGNALING_PATHWAY | 3.47e-03 | 46 | 27 | 2 | MM15950 | |
| Pathway | WP_HEART_DEVELOPMENT | 3.62e-03 | 47 | 27 | 2 | M39610 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 6.03e-09 | 248 | 36 | 7 | 24006456 | |
| Pubmed | 6.86e-07 | 17 | 36 | 3 | 22183742 | ||
| Pubmed | 8.03e-07 | 167 | 36 | 5 | 22159717 | ||
| Pubmed | Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients. | 1.04e-06 | 2 | 36 | 2 | 18182100 | |
| Pubmed | Secretase-dependent tyrosine phosphorylation of Mdm2 by the ErbB-4 intracellular domain fragment. | 1.04e-06 | 2 | 36 | 2 | 15985438 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 27536774 | ||
| Pubmed | Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling. | 1.04e-06 | 2 | 36 | 2 | 26745281 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 31400925 | ||
| Pubmed | The upgraded role of HER3 and HER4 receptors in breast cancer. | 1.04e-06 | 2 | 36 | 2 | 19481955 | |
| Pubmed | Prognostic significance of serum ERBB3 and ERBB4 mRNA in lung adenocarcinoma patients. | 1.04e-06 | 2 | 36 | 2 | 26254096 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 28851073 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 17969526 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 19390858 | ||
| Pubmed | 1.11e-06 | 75 | 36 | 4 | 20637190 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 28653892 | ||
| Pubmed | Expression of ErbB3, ErbB4, and neuregulin-1 mRNA during tooth development. | 3.12e-06 | 3 | 36 | 2 | 12112465 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 30637799 | ||
| Pubmed | An RBCC protein implicated in maintenance of steady-state neuregulin receptor levels. | 3.12e-06 | 3 | 36 | 2 | 11867753 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 22891299 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 7689552 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 9851845 | ||
| Pubmed | ErbB receptor tyrosine kinase family expression levels in urothelial bladder carcinoma. | 3.12e-06 | 3 | 36 | 2 | 23333248 | |
| Pubmed | Expression and potential role of ErbB receptors in type II endometrial cancer. | 3.12e-06 | 3 | 36 | 2 | 23395558 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 9516479 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 28304405 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 9565587 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 18424286 | ||
| Pubmed | Expression and significance of HER family receptors in neuroblastic tumors. | 3.12e-06 | 3 | 36 | 2 | 21203803 | |
| Pubmed | Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival. | 3.12e-06 | 3 | 36 | 2 | 25731189 | |
| Pubmed | High incidence of ErbB3, ErbB4, and MET expression in ovarian cancer. | 3.12e-06 | 3 | 36 | 2 | 24901400 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 16685269 | ||
| Pubmed | Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay. | 6.24e-06 | 4 | 36 | 2 | 24557338 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 19447869 | ||
| Pubmed | Inverse regulation of EGFR/HER1 and HER2-4 in normal and malignant human breast tissue. | 6.24e-06 | 4 | 36 | 2 | 23991224 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 18985033 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 11425901 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 26648299 | ||
| Pubmed | Expression of heregulin, phosphorylated HER-2, HER-3 and HER-4 in HER-2 negative breast cancers. | 6.24e-06 | 4 | 36 | 2 | 19148499 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 22327010 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 22854050 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 17177598 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 9771475 | ||
| Pubmed | Expression of the HER-1-4 family of receptor tyrosine kinases in neuroendocrine tumours. | 6.24e-06 | 4 | 36 | 2 | 20204273 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 21203579 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 15733067 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 27069134 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 8816440 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 21930127 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 26021752 | ||
| Pubmed | Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. | 6.24e-06 | 4 | 36 | 2 | 9168115 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 27777309 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 9019162 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 15254894 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 23723069 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 10572067 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 26886748 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 23137868 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 9342050 | ||
| Pubmed | Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer. | 1.04e-05 | 5 | 36 | 2 | 25416285 | |
| Pubmed | An activated ErbB3/NRG1 autocrine loop supports in vivo proliferation in ovarian cancer cells. | 1.04e-05 | 5 | 36 | 2 | 20227043 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 7589796 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 22554477 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 15682390 | ||
| Pubmed | Neuregulin-1 induces branching morphogenesis in the developing lung through a P13K signal pathway. | 1.04e-05 | 5 | 36 | 2 | 15524405 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 12939402 | ||
| Pubmed | Segregation of receptor and ligand regulates activation of epithelial growth factor receptor. | 1.04e-05 | 5 | 36 | 2 | 12646923 | |
| Pubmed | Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas. | 1.04e-05 | 5 | 36 | 2 | 21407808 | |
| Pubmed | Neuregulins with an Ig-like domain are essential for mouse myocardial and neuronal development. | 1.04e-05 | 5 | 36 | 2 | 8643489 | |
| Pubmed | Ligands for ErbB-family receptors encoded by a neuregulin-like gene. | 1.04e-05 | 5 | 36 | 2 | 9168114 | |
| Pubmed | The human and mouse MHC class III region: a parade of 21 genes at the centromeric segment. | 1.56e-05 | 6 | 36 | 2 | 10871871 | |
| Pubmed | Wnt and Neuregulin1/ErbB signalling extends 3D culture of hormone responsive mammary organoids. | 1.56e-05 | 6 | 36 | 2 | 27782124 | |
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 15358134 | ||
| Pubmed | LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. | 1.56e-05 | 6 | 36 | 2 | 15282549 | |
| Pubmed | The S100A4 Protein Signals through the ErbB4 Receptor to Promote Neuronal Survival. | 1.56e-05 | 6 | 36 | 2 | 30083275 | |
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 11278868 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 15496447 | ||
| Pubmed | 1.90e-05 | 153 | 36 | 4 | 25037231 | ||
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 19609946 | ||
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 8838799 | ||
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 7477375 | ||
| Pubmed | Stretch-induced fetal type II cell differentiation is mediated via ErbB1-ErbB4 interactions. | 2.18e-05 | 7 | 36 | 2 | 22493501 | |
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 20126551 | ||
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 22504067 | ||
| Pubmed | A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk. | 2.18e-05 | 7 | 36 | 2 | 20446891 | |
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 15306553 | ||
| Pubmed | Dynamic expression of Erbb pathway members during early mammary gland morphogenesis. | 2.91e-05 | 8 | 36 | 2 | 17960183 | |
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 16488402 | ||
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 34714866 | ||
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 9693030 | ||
| Pubmed | EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics. | 3.73e-05 | 9 | 36 | 2 | 28988771 | |
| Pubmed | Defects in pathfinding by cranial neural crest cells in mice lacking the neuregulin receptor ErbB4. | 3.73e-05 | 9 | 36 | 2 | 10655590 | |
| Pubmed | 4.06e-05 | 64 | 36 | 3 | 24431302 | ||
| Pubmed | 4.66e-05 | 10 | 36 | 2 | 20881644 | ||
| Pubmed | 4.66e-05 | 10 | 36 | 2 | 19298847 | ||
| Pubmed | 4.66e-05 | 10 | 36 | 2 | 8702723 | ||
| Pubmed | 5.70e-05 | 11 | 36 | 2 | 10821760 | ||
| Pubmed | 5.70e-05 | 11 | 36 | 2 | 20570916 | ||
| Pubmed | 5.70e-05 | 11 | 36 | 2 | 17822758 | ||
| Pubmed | 5.70e-05 | 11 | 36 | 2 | 25315821 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 7.63e-05 | 79 | 36 | 3 | 18757743 | |
| Interaction | SLA2 interactions | 1.03e-05 | 24 | 36 | 3 | int:SLA2 | |
| Cytoband | 1q41 | 1.24e-03 | 66 | 36 | 2 | 1q41 | |
| Cytoband | 12q13 | 1.44e-03 | 71 | 36 | 2 | 12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q41 | 2.45e-03 | 93 | 36 | 2 | chr1q41 | |
| GeneFamily | Erb-b2 receptor tyrosine kinases | 9.27e-06 | 4 | 23 | 2 | 1096 | |
| GeneFamily | Fibronectin type III domain containing | 1.74e-02 | 160 | 23 | 2 | 555 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | LAMC2 CILP2 LTBP2 CRIM1 IGFBP6 CCN1 USH2A SSPOP TNXB VWDE SVEP1 SLIT3 NPNT | 3.04e-19 | 196 | 36 | 13 | M3008 |
| Coexpression | NABA_MATRISOME | LAMC2 CILP2 LTBP2 ADAMTS5 HTRA4 CRIM1 EGFL8 IGFBP6 CCN1 MUC2 USH2A SSPOP TNXB VWDE SVEP1 MEGF10 SLIT3 NPNT WIF1 | 7.09e-18 | 1026 | 36 | 19 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | LAMC2 CILP2 LTBP2 CRIM1 IGFBP6 CCN1 SSPOP TNXB VWDE SVEP1 SLIT3 NPNT | 1.70e-17 | 191 | 36 | 12 | MM17059 |
| Coexpression | NABA_CORE_MATRISOME | LAMC2 CILP2 LTBP2 CRIM1 IGFBP6 CCN1 USH2A SSPOP TNXB VWDE SVEP1 SLIT3 NPNT | 2.62e-17 | 275 | 36 | 13 | M5884 |
| Coexpression | NABA_MATRISOME | LAMC2 CILP2 LTBP2 ADAMTS5 HTRA4 CRIM1 EGFL8 IGFBP6 CCN1 MUC2 SSPOP TNXB VWDE SVEP1 MEGF10 SLIT3 NPNT WIF1 | 1.38e-16 | 1008 | 36 | 18 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | LAMC2 CILP2 LTBP2 CRIM1 IGFBP6 CCN1 SSPOP TNXB VWDE SVEP1 SLIT3 NPNT | 1.12e-15 | 270 | 36 | 12 | MM17057 |
| Coexpression | HAY_BONE_MARROW_STROMAL | 6.96e-07 | 767 | 36 | 9 | M39209 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | 4.23e-06 | 955 | 36 | 9 | M45680 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 1.09e-05 | 1074 | 36 | 9 | M1941 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 2.27e-05 | 40 | 36 | 3 | M5887 | |
| Coexpression | FAN_EMBRYONIC_CTX_IN_3_INTERNEURON | 2.74e-05 | 6 | 36 | 2 | M39029 | |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | 6.54e-05 | 313 | 36 | 5 | M40228 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING | 8.04e-05 | 327 | 36 | 5 | MM3714 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | 9.47e-05 | 550 | 36 | 6 | M16189 | |
| Coexpression | DELPUECH_FOXO3_TARGETS_UP | 9.80e-05 | 65 | 36 | 3 | M2313 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | 1.16e-04 | 571 | 36 | 6 | MM1100 | |
| Coexpression | LINDVALL_IMMORTALIZED_BY_TERT_DN | 1.39e-04 | 73 | 36 | 3 | M1561 | |
| Coexpression | GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_UP | 1.60e-04 | 200 | 36 | 4 | M7268 | |
| Coexpression | LIU_TOPBP1_TARGETS | 1.65e-04 | 14 | 36 | 2 | M2382 | |
| Coexpression | PEREZ_TP53_TARGETS | 1.82e-04 | 1201 | 36 | 8 | M4391 | |
| Coexpression | CHANG_POU5F1_TARGETS_UP | 1.90e-04 | 15 | 36 | 2 | M9138 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | 2.16e-04 | 404 | 36 | 5 | M19488 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN | 2.18e-04 | 85 | 36 | 3 | M7012 | |
| Coexpression | AIZARANI_LIVER_C7_EPCAM_POS_BILE_DUCT_CELLS_2 | 2.26e-04 | 219 | 36 | 4 | M39111 | |
| Coexpression | COLDREN_GEFITINIB_RESISTANCE_DN | 2.73e-04 | 230 | 36 | 4 | M6744 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 2.77e-04 | 18 | 36 | 2 | M13796 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 2.77e-04 | 18 | 36 | 2 | MM1241 | |
| Coexpression | DESCARTES_ORGANOGENESIS_SCHWANN_CELL_PRECURSOR | 3.31e-04 | 98 | 36 | 3 | MM3656 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL | 3.60e-04 | 704 | 36 | 6 | M45672 | |
| Coexpression | FINETTI_BREAST_CANCERS_KINOME_BLUE | 3.79e-04 | 21 | 36 | 2 | M2862 | |
| Coexpression | KAAB_HEART_ATRIUM_VS_VENTRICLE_UP | 4.09e-04 | 256 | 36 | 4 | M10952 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 4.40e-04 | 261 | 36 | 4 | M1834 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 4.56e-04 | 23 | 36 | 2 | M48001 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 4.62e-04 | 738 | 36 | 6 | MM17058 | |
| Coexpression | OSADA_ASCL1_TARGETS_DN | 4.97e-04 | 24 | 36 | 2 | M4336 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 5.00e-04 | 270 | 36 | 4 | M19432 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 5.07e-04 | 751 | 36 | 6 | M5885 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN | 5.28e-04 | 491 | 36 | 5 | MM455 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 6.05e-04 | 284 | 36 | 4 | MM987 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 6.43e-04 | 123 | 36 | 3 | M624 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS | 6.46e-04 | 289 | 36 | 4 | M41750 | |
| Coexpression | RASHI_RESPONSE_TO_IONIZING_RADIATION_2 | 6.74e-04 | 125 | 36 | 3 | M5888 | |
| Coexpression | RASHI_RESPONSE_TO_IONIZING_RADIATION_2 | 7.06e-04 | 127 | 36 | 3 | MM1113 | |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | 7.61e-04 | 302 | 36 | 4 | MM16604 | |
| Coexpression | SIMBULAN_PARP1_TARGETS_UP | 7.79e-04 | 30 | 36 | 2 | M1550 | |
| Coexpression | POOLA_INVASIVE_BREAST_CANCER_DN | 8.07e-04 | 133 | 36 | 3 | M6767 | |
| Coexpression | SIMBULAN_PARP1_TARGETS_UP | 8.32e-04 | 31 | 36 | 2 | MM665 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | 8.38e-04 | 544 | 36 | 5 | M1936 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 8.42e-04 | 135 | 36 | 3 | MM965 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 9.38e-06 | 453 | 36 | 7 | GSM777067_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.10e-05 | 464 | 36 | 7 | JC_fibro_1000_K1 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 2.15e-05 | 97 | 36 | 4 | GSM777046_100 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500_k-means-cluster#3 | 2.42e-05 | 206 | 36 | 5 | JC_fibro_500_K3 | |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 3.26e-05 | 761 | 36 | 8 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | 6.60e-05 | 1094 | 36 | 9 | ratio_EB_vs_SC_2500_K3 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 8.47e-05 | 437 | 36 | 6 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 1.06e-04 | 455 | 36 | 6 | GSM777055_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.20e-04 | 466 | 36 | 6 | GSM777050_500 | |
| CoexpressionAtlas | EB blastocyst_vs_EB amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 1.43e-04 | 300 | 36 | 5 | PCBC_ratio_EB blastocyst_vs_EB amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.55e-04 | 951 | 36 | 8 | Arv_EB-LF_2500_K2 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_200 | 2.09e-04 | 174 | 36 | 4 | gudmap_kidney_adult_RenalCapsule_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.43e-04 | 336 | 36 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 2.48e-04 | 182 | 36 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | BM Top 100 - thyroid gland | 2.57e-04 | 73 | 36 | 3 | BM Top 100 - thyroid gland | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | 2.84e-04 | 778 | 36 | 7 | gudmap_kidney_adult_RenalCapsule_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | 2.96e-04 | 783 | 36 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 5.27e-04 | 398 | 36 | 5 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_top-relative-expression-ranked_500 | 5.45e-04 | 401 | 36 | 5 | gudmap_developingKidney_e11.5_ureteric bud_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | 5.90e-04 | 408 | 36 | 5 | gudmap_kidney_adult_RenalCapsule_500 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSK-L-l-p53KD_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 6.28e-04 | 99 | 36 | 3 | PCBC_ratio_MESO-5_from-OSK-L-l-p53KD_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.39e-04 | 243 | 36 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-10 | 188 | 36 | 7 | e18065bbc26d6f3774fd1f478fb41d8fb555fa26 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.01e-10 | 196 | 36 | 7 | 988a3e0688e0a7ba69774497d3b130631bb26c50 | |
| ToppCell | (2)_Fibroblasts-(23)_Fibro-4|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.15e-10 | 198 | 36 | 7 | e0ef49ec0f87cc87b45efa297b9ff6c35b7a2ba9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.23e-10 | 199 | 36 | 7 | 0019cfaa586a450c2e4952d1184a540561c8d0ba | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.23e-10 | 199 | 36 | 7 | 4e128c705ad36fd840582848f278770f356fcc8b | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.31e-10 | 200 | 36 | 7 | 0a86656d48e4238d0e4d592d477d29f7ba7c2ec0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.31e-10 | 200 | 36 | 7 | 3fa7d9ea67f9cc55478d085da53babd03dbe9bb1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-10 | 200 | 36 | 7 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.31e-10 | 200 | 36 | 7 | 1e75d1302c22e1b1666c19c0c9259d5cc8be16d5 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-10 | 200 | 36 | 7 | 2e4ab7fbd94d3d865ef6188d3b4916d2bf1b8d89 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.34e-09 | 183 | 36 | 6 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.83e-09 | 185 | 36 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.90e-09 | 189 | 36 | 6 | 40cbd679dc0548bf5207e1b033c0597886ad6fe1 | |
| ToppCell | Fibroblast-C|World / shred on cell class and cell subclass (v4) | 8.90e-09 | 189 | 36 | 6 | 58e0400fbab5a0755504275aef5cf7986149abab | |
| ToppCell | droplet-Lung-immune-endo-depleted|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.90e-09 | 189 | 36 | 6 | c3fb363bb0156ffb3367c200f548faebda64ab4a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.90e-09 | 189 | 36 | 6 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | facs-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.90e-09 | 189 | 36 | 6 | bdf8db938aa0863c4fed6fa99dcffd63c8c20c31 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.90e-09 | 189 | 36 | 6 | 2a2953f6b1b7d070d739dcaf7285fce6e097d9e4 | |
| ToppCell | droplet-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.90e-09 | 189 | 36 | 6 | 5a636e952da9b1fd26aa17f7b129054f2da322b5 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-09 | 190 | 36 | 6 | 9cd147a174017ebda23cc47b6d4552d898acd092 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.48e-09 | 191 | 36 | 6 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.48e-09 | 191 | 36 | 6 | ce80f65bd24b1c4d2152bf45248449e7a1a97e56 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.48e-09 | 191 | 36 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.78e-09 | 192 | 36 | 6 | 41a8326cd5bc19ad5041068501bab4c72399222e | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.78e-09 | 192 | 36 | 6 | f88aba74d6e8c594c32fe2bc095b5da28b4b28e9 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.78e-09 | 192 | 36 | 6 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-09 | 192 | 36 | 6 | 5876ff75e273a48e7ad8236423fb41e4ae4c0a91 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.04e-08 | 194 | 36 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-08 | 195 | 36 | 6 | 47762d9e442fb1f6f0033e3e10f4c6e498d2c081 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-08 | 195 | 36 | 6 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-08 | 195 | 36 | 6 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-08 | 196 | 36 | 6 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-08 | 196 | 36 | 6 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.11e-08 | 196 | 36 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-08 | 197 | 36 | 6 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-08 | 197 | 36 | 6 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-08 | 197 | 36 | 6 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 1.14e-08 | 197 | 36 | 6 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-08 | 198 | 36 | 6 | aed0476248e9637897eefb1623ec4035f2dacd82 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-08 | 198 | 36 | 6 | 691a2f1779225e5519155460eeb6a2aac5f67a92 | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 1.17e-08 | 198 | 36 | 6 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.17e-08 | 198 | 36 | 6 | e115eea04012e9e492e923ed080e1723c38d14fd | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.17e-08 | 198 | 36 | 6 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.17e-08 | 198 | 36 | 6 | 33d1e0b6f57663544bee0ffdde83a65da764d44c | |
| ToppCell | Severe_COVID-19-Epithelial-AT1/AT2|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.17e-08 | 198 | 36 | 6 | 43e33d28d9de5033bd00d39be953542a225236ed | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.17e-08 | 198 | 36 | 6 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-08 | 198 | 36 | 6 | aae663c6da70b6e716edeed50cc7d3962d78e697 | |
| ToppCell | Control-Stromal|Control / Disease state, Lineage and Cell class | 1.17e-08 | 198 | 36 | 6 | ae726b6b7f0a4107899be4d32ac256ffa0bd8d59 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-08 | 199 | 36 | 6 | 4032f03a4165f5f2a90ef1d8315cc743ce9075bb | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.21e-08 | 199 | 36 | 6 | 28c1722deef3b8347371c7359be7c64b95780de3 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.21e-08 | 199 | 36 | 6 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | distal-2-mesenchymal-Myofibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.21e-08 | 199 | 36 | 6 | b8f3cf5bcfde1066bdb49b14fdc842fe9692a6b7 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.21e-08 | 199 | 36 | 6 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.21e-08 | 199 | 36 | 6 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-08 | 199 | 36 | 6 | a538da095ba996ee96e263442cf5b6ba9178f3d4 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.25e-08 | 200 | 36 | 6 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-08 | 200 | 36 | 6 | f6be0f24e607abb9007823a54fb0b24d04990a89 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-08 | 200 | 36 | 6 | 933b5b400e48a511ba0a056be1d33d3610b5f10d | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Fibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.25e-08 | 200 | 36 | 6 | 8d75ce89393df452defacf2ec9a5bd4b7708afbb | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.25e-08 | 200 | 36 | 6 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | cellseq-Mesenchymal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.25e-08 | 200 | 36 | 6 | 238285fc372ce2e5e4341fc3084a3a833bf4a0a6 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.25e-08 | 200 | 36 | 6 | be527df943a8cedc6452ecef3cafc282db34ceb8 | |
| ToppCell | distal-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.25e-08 | 200 | 36 | 6 | 12b705dabec1b3752a488a891eda1a5123fcdc41 | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.25e-08 | 200 | 36 | 6 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-08 | 200 | 36 | 6 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-08 | 200 | 36 | 6 | b04831708fa20471a127b87e8db3728b6e729ce8 | |
| ToppCell | 343B-Fibroblasts|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-08 | 200 | 36 | 6 | 376c1a77031e090be96948b47c78ac0d393f5775 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-08 | 200 | 36 | 6 | 6316c288022719b9e6c4332c5cb9041e1188d0e8 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-08 | 200 | 36 | 6 | cfea2f9d85646c9b722150551ff2e8fc4f6cc98a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.25e-08 | 200 | 36 | 6 | 3e6730c9ed7003a4acf501f699a4965a7a50f946 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-08 | 200 | 36 | 6 | c935caef2988f165e96d8f1ef99ae8963ab9377f | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-08 | 200 | 36 | 6 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | tumor_Lung-Fibroblasts|tumor_Lung / Location, Cell class and cell subclass | 1.25e-08 | 200 | 36 | 6 | 073a68b5ce232203ffee86342cba2a00d907e119 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-08 | 200 | 36 | 6 | 6b48ddde83bc6c941d557844aa214d4d2c8e736d | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-08 | 200 | 36 | 6 | fd92d8250c6ad1e8bb46b303ac37f8dcf80387d8 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.25e-08 | 200 | 36 | 6 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.25e-08 | 200 | 36 | 6 | bfa73bc5f8a6c7de8353ca049a921ef19f7f4437 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.25e-08 | 200 | 36 | 6 | 8e41a484038216f0c2ad258fd46c0e702a4bb8bf | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-08 | 200 | 36 | 6 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.25e-08 | 200 | 36 | 6 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.25e-08 | 200 | 36 | 6 | 56536236a7012efdb28f85b40e464f3da3e87ce8 | |
| ToppCell | distal-3-mesenchymal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.25e-08 | 200 | 36 | 6 | 7a79a2de78325d4f1c4535969106a0a44249028c | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.25e-08 | 200 | 36 | 6 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-08 | 126 | 36 | 5 | c3261ea8726400de87f1c8a5a5134ba2b2884f66 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.72e-07 | 173 | 36 | 5 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.79e-07 | 174 | 36 | 5 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.87e-07 | 175 | 36 | 5 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.96e-07 | 176 | 36 | 5 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.96e-07 | 176 | 36 | 5 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-07 | 177 | 36 | 5 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-07 | 177 | 36 | 5 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-07 | 178 | 36 | 5 | 6d9ecfaeb50d562899380de379ebf7b99fd8adc9 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-07 | 178 | 36 | 5 | d3f518cd75b02e85d45cbb9b2eff30f0272512a8 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.22e-07 | 179 | 36 | 5 | dcd0a83f0592ae27f814d064b4791f84c3c86e64 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.22e-07 | 179 | 36 | 5 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-07 | 180 | 36 | 5 | f9f8245cbcdea18c15e2976c85b72c6807309787 | |
| ToppCell | tumor_Lung-Fibroblasts-Undetermined|tumor_Lung / Location, Cell class and cell subclass | 3.40e-07 | 181 | 36 | 5 | 53bcab4d6df4a3255d81877ba22fb95d4492ce9f | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.49e-07 | 182 | 36 | 5 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-07 | 183 | 36 | 5 | 5cfcd589a480e67654d3d94e71916f122150db10 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-07 | 183 | 36 | 5 | c3ea8d3b916ffcaca3156e0d77a952724554c4ab | |
| Computational | DRG (dorsal root ganglia) genes. | 1.56e-04 | 384 | 24 | 6 | MODULE_2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.58e-04 | 48 | 24 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PI16_POS | |
| Computational | Lung genes. | 3.03e-04 | 434 | 24 | 6 | MODULE_5 | |
| Computational | IGFBPs. | 3.11e-04 | 12 | 24 | 2 | MODULE_190 | |
| Computational | Genes in the cancer module 474. | 6.37e-04 | 17 | 24 | 2 | MODULE_474 | |
| Computational | Ovary genes. | 1.14e-03 | 368 | 24 | 5 | MODULE_1 | |
| Drug | Tribenoside [10310-32-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.30e-05 | 194 | 36 | 5 | 3507_UP | |
| Drug | Paclitaxel | 1.33e-05 | 720 | 36 | 8 | ctd:D017239 | |
| Drug | PD168393 | 1.46e-05 | 4 | 36 | 2 | CID000004708 | |
| Drug | Mephenytoin [50-12-4]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 1.47e-05 | 199 | 36 | 5 | 3580_UP | |
| Drug | RG 14921 | 2.42e-05 | 5 | 36 | 2 | CID000197517 | |
| Drug | 6-quinolinecarbaldehyde | 2.42e-05 | 5 | 36 | 2 | CID000765653 | |
| Drug | SnCe6 | 3.63e-05 | 6 | 36 | 2 | CID000164259 | |
| Drug | Cochliobolic acid | 3.63e-05 | 6 | 36 | 2 | CID006450172 | |
| Drug | diethyl ester | 3.63e-05 | 6 | 36 | 2 | CID000264327 | |
| Drug | SSFSB | 5.08e-05 | 7 | 36 | 2 | CID003035734 | |
| Drug | RG 14467 | 5.08e-05 | 7 | 36 | 2 | CID000132069 | |
| Drug | IC 261 | 5.08e-05 | 7 | 36 | 2 | ctd:C411652 | |
| Drug | PKI166 | 5.98e-05 | 48 | 36 | 3 | CID006918403 | |
| Drug | mono-(2-ethylhexyl)phthalate | 6.56e-05 | 658 | 36 | 7 | ctd:C016599 | |
| Drug | 6-(methylamino)pyrido(3,4-d)pyrimidine | 1.09e-04 | 10 | 36 | 2 | ctd:C107875 | |
| Drug | H 661 | 1.09e-04 | 10 | 36 | 2 | CID003056529 | |
| Drug | BE-23372M | 1.32e-04 | 11 | 36 | 2 | CID005311105 | |
| Drug | 4,5-dianilinophthalimide | 1.32e-04 | 11 | 36 | 2 | CID000001697 | |
| Drug | 2nq6 | 1.88e-04 | 13 | 36 | 2 | CID011809364 | |
| Drug | 1,5-AG | 1.91e-04 | 182 | 36 | 4 | CID000064960 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.91e-04 | 182 | 36 | 4 | 2321_UP | |
| Drug | Corticosterone [50-22-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.99e-04 | 184 | 36 | 4 | 3244_UP | |
| Drug | Fluorouracil | 2.09e-04 | 1364 | 36 | 9 | ctd:D005472 | |
| Drug | Mifepristone | 2.09e-04 | 553 | 36 | 6 | ctd:D015735 | |
| Drug | mercuric bromide | 2.25e-04 | 1076 | 36 | 8 | ctd:C042720 | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.29e-04 | 191 | 36 | 4 | 6498_UP | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 10uM; PC3; HT_HG-U133A | 2.29e-04 | 191 | 36 | 4 | 3823_DN | |
| Drug | Clemastine fumarate [14976-57-9]; Up 200; 8.6uM; HL60; HT_HG-U133A | 2.38e-04 | 193 | 36 | 4 | 2412_UP | |
| Drug | Flurandrenolide [1524-88-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.43e-04 | 194 | 36 | 4 | 6039_DN | |
| Drug | Estrone [53-16-7]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 2.48e-04 | 195 | 36 | 4 | 6448_UP | |
| Drug | Medrysone [2668-66-8]; Up 200; 11.6uM; HL60; HT_HG-U133A | 2.48e-04 | 195 | 36 | 4 | 2544_UP | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; PC3; HT_HG-U133A | 2.48e-04 | 195 | 36 | 4 | 4495_DN | |
| Drug | 2aq7 | 2.52e-04 | 15 | 36 | 2 | CID005494446 | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; PC3; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 4582_UP | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 2802_UP | |
| Drug | Dimenhydrinate [523-87-5]; Up 200; 8.6uM; PC3; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 6352_UP | |
| Drug | Urosiol [128-13-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 6484_UP | |
| Drug | Dosulepin hydrochloride [897-15-4]; Up 200; 12uM; MCF7; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 5986_UP | |
| Drug | Ungerine nitrate; Up 200; 10.2uM; HL60; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 2514_UP | |
| Drug | Deptropine citrate [2169-75-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 5543_UP | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; PC3; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 6690_UP | |
| Drug | Cyclopentolate hydrochloride [5870-29-1]; Up 200; 12.2uM; HL60; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 6132_UP | |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; MCF7; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 4775_UP | |
| Drug | 4-anilinoquinazoline | 2.88e-04 | 16 | 36 | 2 | CID000324081 | |
| Drug | propanedinitrile | 2.88e-04 | 16 | 36 | 2 | CID000008010 | |
| Drug | Etoposide | 2.89e-04 | 587 | 36 | 6 | ctd:D005047 | |
| Drug | AC1L1G2K | 3.17e-04 | 84 | 36 | 3 | CID000003498 | |
| Disease | pulse pressure measurement | 3.29e-06 | 1392 | 35 | 10 | EFO_0005763 | |
| Disease | urinary bladder cancer (is_marker_for) | 7.85e-06 | 107 | 35 | 4 | DOID:11054 (is_marker_for) | |
| Disease | FEV/FEC ratio | 9.64e-06 | 1228 | 35 | 9 | EFO_0004713 | |
| Disease | serum alanine aminotransferase measurement | 6.14e-05 | 869 | 35 | 7 | EFO_0004735 | |
| Disease | Schizophrenia | 6.78e-05 | 883 | 35 | 7 | C0036341 | |
| Disease | gallbladder neoplasm | 7.47e-05 | 11 | 35 | 2 | C0016978 | |
| Disease | Malignant neoplasm of gallbladder | 7.47e-05 | 11 | 35 | 2 | C0153452 | |
| Disease | progression free survival, urinary bladder cancer | 8.95e-05 | 12 | 35 | 2 | EFO_0004920, MONDO_0001187 | |
| Disease | median neuropathy (biomarker_via_orthology) | 1.23e-04 | 14 | 35 | 2 | DOID:571 (biomarker_via_orthology) | |
| Disease | cognitive function measurement | 2.22e-04 | 1434 | 35 | 8 | EFO_0008354 | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 2.31e-04 | 19 | 35 | 2 | DOID:2876 (is_marker_for) | |
| Disease | e-selectin measurement | 3.11e-04 | 22 | 35 | 2 | EFO_0004575 | |
| Disease | stomach carcinoma (is_marker_for) | 3.71e-04 | 24 | 35 | 2 | DOID:5517 (is_marker_for) | |
| Disease | coronary artery disease | 4.34e-04 | 1194 | 35 | 7 | EFO_0001645 | |
| Disease | Mental deterioration | 5.44e-04 | 29 | 35 | 2 | HP_0001268 | |
| Disease | intestinal cancer (implicated_via_orthology) | 6.63e-04 | 32 | 35 | 2 | DOID:10155 (implicated_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, C-reactive protein measurement | 7.94e-04 | 35 | 35 | 2 | EFO_0004458, EFO_0004611 | |
| Disease | prostate cancer (is_marker_for) | 8.38e-04 | 156 | 35 | 3 | DOID:10283 (is_marker_for) | |
| Disease | tongue squamous cell carcinoma (is_marker_for) | 8.87e-04 | 37 | 35 | 2 | DOID:0050865 (is_marker_for) | |
| Disease | ductal carcinoma in situ (is_marker_for) | 9.85e-04 | 39 | 35 | 2 | DOID:0060074 (is_marker_for) | |
| Disease | Disease Exacerbation | 9.85e-04 | 165 | 35 | 3 | C0235874 | |
| Disease | anthropometric measurement | 1.04e-03 | 168 | 35 | 3 | EFO_0004302 | |
| Disease | response to antihypertensive drug | 1.09e-03 | 41 | 35 | 2 | EFO_0005405 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QGCVGPRRGCCAPVQ | 26 | O00154 | |
| RPCHENCTQGCKGPE | 611 | P21860 | |
| GPNCVEKCPDGLQGA | 586 | Q15303 | |
| KPCLNGGVCVRPDQC | 116 | Q99944 | |
| GGVCVRPDQCECAPG | 121 | Q99944 | |
| PCGKGRICLQGKCVD | 541 | Q9UNA0 | |
| PGVGLVRDGCGCCKV | 41 | O00622 | |
| GQCPCKPGVIGRQCD | 1941 | Q9HCU4 | |
| CRCLGPQGTCGQIPL | 1131 | Q96F81 | |
| QAGQEPGPGEKRACC | 196 | P57735 | |
| GPQCEQRCPCQNGGV | 231 | Q96KG7 | |
| LLCPGCQGQPQGKAV | 206 | Q8IYF1 | |
| QPRCKHGECIGPNKC | 61 | Q6UXI9 | |
| CVKTCGCVGPDNVPR | 4811 | Q02817 | |
| EVGCSPCGAPDQKCR | 591 | Q9Y4D8 | |
| ENNCRCPGPVRGGKE | 2381 | Q8NFC6 | |
| EREVCGGAQGQPCAP | 76 | P83105 | |
| GAGVPACTPCKQPRC | 201 | Q9UF56 | |
| VCNPAGCLRKVCQPG | 211 | Q9NZV1 | |
| GRLTGRNVCGGQCCP | 161 | Q14767 | |
| IAGPCDAGRCVCKPA | 146 | Q13753 | |
| RLGPFGTCIPCNCQG | 406 | Q13753 | |
| LARCPGCGQGVQAGC | 26 | P24592 | |
| GQRCRLCPAPGDCQV | 91 | Q14D33 | |
| GQCPCKLGVTGLRCN | 866 | O75445 | |
| QCGPGQTPCEVLGCV | 2391 | A2VEC9 | |
| CEKGELLCQPGGCPL | 2701 | A2VEC9 | |
| GCRCPPGQLVQDGRC | 4706 | A2VEC9 | |
| ICVQEPCQPGCGCPG | 4846 | A2VEC9 | |
| LVCDGPNGCKCLGPE | 1296 | Q8NDG6 | |
| EPCVICQGRPKNGCI | 436 | Q00987 | |
| GAGCMCPPLPCQQEA | 356 | P31391 | |
| CQSPCLNGGKCVRPN | 3536 | Q4LDE5 | |
| NCPGVINPGECKIGI | 171 | P53597 | |
| AECGCQKCLPPRGLV | 461 | Q8IUL8 | |
| MECRGGCGPQCCQPT | 1476 | O75094 | |
| GGQCLTPDICQCKPG | 1401 | Q8N2E2 | |
| PSCPGDCQGRGRCVQ | 216 | P22105 | |
| VKEGCPGLCNGNGRC | 796 | Q6N022 | |
| SKCPQPCRNGGKCIG | 276 | Q9Y5W5 | |
| GGCVNLGLPCPAECQ | 366 | O43435 |